Clinical Trial Update: Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR) [Phase 3]

View source ↗

Summary

Phase 3 randomized open-label trial evaluating hypertonic saline and carbocisteine in bronchiectasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Carbocisteine (carbocisteine)
• Hypertonic Saline (Hypertonic saline)

Snippet

Sponsor: Belfast Health and Social Care Trust | Conditions: Bronchiectasis | Phase 3 | Status: COMPLETED